Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -0.17% is 101% below its 5-year average of 24.60%, near the low end of its 5-year range (-0.17%–32.11%).
As of the fiscal period ended Wednesday, December 31, 2025. 100.90% below its 12-month average of 18.91%.
Annual fiscal-year return on equity; no daily interpolation.
RETURN ON EQUITY (ROE)
-0.17%
RETURN ON EQUITY (ROE) AVG TTM
18.91%
RETURN ON EQUITY (ROE) AVG 3Y
22.60%
RETURN ON EQUITY (ROE) AVG 5Y
24.60%
RETURN ON EQUITY (ROE) AVG 10Y
18.14%
RETURN ON EQUITY (ROE) AVG 15Y
17.44%
RETURN ON EQUITY (ROE) AVG 20Y
15.47%
CURRENT VS TTM AVG
-100.90%
CURRENT VS 3Y AVG
-100.75%
CURRENT VS 5Y AVG
-100.69%
CURRENT VS 10Y AVG
-100.94%
CURRENT VS 15Y AVG
-100.98%
CURRENT VS 20Y AVG
-101.10%
SECTOR MEDIAN · HEALTHCARE
12.09%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-101.41%
vs the sector median at left
Molina Healthcare, Inc.
Market Cap
$10.25B
Return on Equity (ROE)
-0.17%
TTM Avg
18.91%
3Y Avg
22.60%
5Y Avg
24.60%
Market Cap
$10.37B
Return on Equity (ROE)
-87.68%
TTM Avg
-49.03%
3Y Avg
-18.16%
5Y Avg
-9.00%
Market Cap
$10.04B
Return on Equity (ROE)
12.09%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$10.51B
Return on Equity (ROE)
20.31%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
Market Cap
$9.78B
Return on Equity (ROE)
26.39%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
Market Cap
$9.49B
Return on Equity (ROE)
3.10%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
Market Cap
$11.32B
Return on Equity (ROE)
5.25%
TTM Avg
5.98%
3Y Avg
10.62%
5Y Avg
11.34%
Market Cap
$9.12B
Return on Equity (ROE)
-57.18%
TTM Avg
-651.33%
3Y Avg
-315.37%
5Y Avg
-198.08%
Market Cap
$11.80B
Return on Equity (ROE)
-114.70%
TTM Avg
329.18%
3Y Avg
200.63%
5Y Avg
164.66%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Molina Healthcare, Inc. (MOH) | $10.25B | -0.17% | 18.91% | 22.60% | 24.60% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -87.68% | -49.03% | -18.16% | -9.00% |
| Henry Schein, Inc. (HSIC)vs › | $10.04B | 12.09% | 11.88% | 12.69% | 13.50% |
| Universal Health Services, Inc. (UHS)vs › | $10.51B | 20.31% | 18.80% | 15.17% | 15.31% |
| Insulet Corp. (PODD)vs › | $9.78B | 26.39% | 25.41% | 19.99% | 14.02% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.49B | 3.10% | -8.94% | -15.72% | 1.14% |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 5.25% | 5.98% | 10.62% | 11.34% |
| Tempus AI, Inc. (TEM)vs › | $9.12B | -57.18% | -651.33% | -315.37% | -198.08% |
| DaVita Inc. (DVA)vs › | $11.80B | -114.70% | 329.18% | 200.63% | 164.66% |
| Align Technology, Inc. (ALGN)vs › | $12.44B | 9771.59% | 10.54% | 10.84% | 19.93% |
ROE
-0.2%
ROA
-0.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | 11.60% |
| 2024-12-31 | 26.22% |
| 2023-12-31 | 25.88% |
| 2022-12-31 | 26.72% |
| 2021-12-31 | 25.06% |
| 2020-12-31 | 32.11% |
| 2019-12-31 | 37.60% |
| 2018-12-31 | 42.93% |
| 2017-12-31 | -38.29% |
| 2016-12-31 | 0.49% |
| 2015-12-31 | 9.18% |
| 2014-12-31 | 6.16% |
| 2013-12-31 | 5.93% |
| 2012-12-31 | 1.25% |
| 2011-12-31 | 2.76% |
| 2010-12-31 | 7.64% |
| 2009-12-31 | 5.69% |
| 2008-12-31 | 11.73% |
| 2007-12-31 | 11.89% |
| 2006-12-31 | 10.88% |
| 2005-12-31 | 7.61% |
| 2004-12-31 | 16.87% |
| 2003-12-31 | 19.21% |
| 2002-12-31 | 32.02% |
| 2001-12-31 | 46.52% |
| 2000-12-31 | 43.24% |
| 1999-12-31 | 45.79% |
